6,175 results
·
40ms
·
Sources: EU EUDAMED, US FDA
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 PHARMDX
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·STAR S4 IR Excimer Laser System and iDesign Advanced WaveScan Studio System
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·STAR EXCIMER LASER SYSTEM AND IDESIGN ADVANCED WAVESCAN STUDIO
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-Ll (SP142) Assay
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1 (SP263) Assay
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·WAVELIGHT EX500 EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·STAR S4 ACTIVETRAK EXCIMER LASER SYSTEM AND WAVESCAN WAVEFRONT SYSTEM
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-Ll (SP142) Assay
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1(SP142) Assay
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1 (SP263) Assay
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·VISX STARR S3 EXCIMER LASER SYSTEM (WITH EYE TRACKER)
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·WaveLight EX500 Laser System with Patient Bed Swivel 1125
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·ALLEGRETTO WAVE EYE-Q EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·WAVESCAN WAVEFRONT SYSTEM SOFTWARE VERSION 3.68
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·ALLEGRO TOPOLYZER VARIO
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·BAUSCH & LOMB TECHNOLAS T217Z ZYOPTIX LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·INFINITY LS EXCIMER LASER SYSTEM
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 pharmDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 PHARMDX (Melanoma Indication)
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·VISX EXCIMER LASER SYSTEM MODEL C STAR